dermatan sulfate has been researched along with Disease Models, Animal in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (14.81) | 18.7374 |
1990's | 11 (20.37) | 18.2507 |
2000's | 13 (24.07) | 29.6817 |
2010's | 17 (31.48) | 24.3611 |
2020's | 5 (9.26) | 2.80 |
Authors | Studies |
---|---|
Capitani, F; D'Avanzo, F; Gabrielli, O; Galeotti, F; Maccari, F; Mantovani, V; Rigon, L; Salvalaio, M; Tomanin, R; Volpi, N; Zanetti, A | 1 |
Bocart, S; Bouchot, A; Bournique, B; Broqua, P; Entchev, E; Jantzen, I; Junien, JL; Lacombe, O; Luccarini, JM; Masson, P; Tallandier, M | 1 |
Arguello, A; Astarita, G; Bhalla, A; Costanzo, S; Davis, SS; Dugas, JC; Fang, M; Gunasekaran, K; Guo, JL; Harris, JM; Henne, KR; Henry, AG; Poda, SB; Ravi, R; Skuja, LL; Sweeney, ZK; Thomsen, E; Tsogtbaatar, B; Ullman, JC; Wang, J | 1 |
Daniel, RA; Desilva, K; Du, QS; Masci, PP; Osborne, SA; Seymour, RB; Vitetta, L; Zhao, KN | 1 |
Coulson-Thomas, VJ; Elliott, G; Gesteira, TF; Hughes, C; Moreno, IY; Mutoji, KN; Sun, M | 1 |
Dörr, W; Frings, K; Gruber, S; Kuess, P | 1 |
Amling, M; Busse, B; Chan, D; Chan, WL; Egerer, J; Hausser, I; Khayal, LA; Knaus, P; Kolanczyk, M; Kornak, U; Lowe, M; Mizumoto, S; Mundlos, S; Ott, CE; Paganini, C; Pestka, JM; Rossi, A; Schinke, T; Steiner, M; Sugahara, K; Willie, B; Witkos, T; Zhang, H | 1 |
Arnold, M; Cini, N; Dörr, W; Gernedl, V; Gruber, S; Hetzendorfer, S; Kowald, LM; Kuess, P; Mayer, J; Morava, S; Pfaffinger, S; Rohorzka, A | 1 |
Kida, S; Kinoshita, M; Morimoto, H; Shibasaki, T; Tachibana, K; Tanaka, N; Yamamoto, R | 1 |
Gao, W; Li, W; Xu, J; Xu, S; Yu, Z | 1 |
Kawano, H; Kimura-Kuroda, J; Komuta, Y; Li, HP; van Kuppevelt, TH | 1 |
Baracat, EC; Gomes, RC; Maioral, GC; Nader, HB; Patriarca, MT; Simões, RS; Soares, JM; Verna, C | 1 |
Bravo, AI; Calabrese, GC; Gazzaniga, S; Maccari, F; Oberkersch, R; Volpi, N | 1 |
Eklund, E; Grottling, E; Gustafsson, R; Maccarana, M; Malmström, A; Oldberg, A; Stachtea, X | 1 |
Akyüz, N; Huckhagel, T; Jakovcevski, I; Martinovic, T; Rost, S; Schachner, M | 1 |
Bavington, CD; Hogwood, J; Moss, C; Mulloy, B; Page, CP; Panagos, CG; Robinson, J; Spina, D; Thomson, D; Uhrín, D; Venkatasamy, R | 1 |
Akiyama, K; Higuchi, T; Ida, H; Kobayashi, H; Nakauchi, H; Ohashi, T; Ohteki, T; Otsu, M; Sato, T; Shimada, Y; Yokoi, K; Yokoi, T | 1 |
Arasaradnam, M; Bigger, BW; Langford-Smith, K; Wraith, JE; Wynn, R | 1 |
Hagiwara, S; Iwasaka, H; Matsumoto, S; Mizunaga, S; Nishida, T; Noguchi, T; Saikawa, T; Shingu, C; Uchida, T | 1 |
Kolb, M; Ludwig, MS; Netter, P; Ouzzine, M; Venkatesan, N | 1 |
Belmiro, CL; Gonçalves, RG; Kozlowski, EO; Leite, M; Pavão, MS; Takyia, CM; Werneck, AF | 1 |
Lagarde, N; Marcorelles, P; Uguen, A; Zanchetta, P | 1 |
Roehrl, MH; Wang, JY | 1 |
He, L; Pavão, MS; Tollefsen, DM; Vicente, CP | 1 |
Cardin, AD; Hong, TT; Lucchesi, BR; Van Gorp, CL | 1 |
Gonçalves, RG; Leite, M; Martinusso, CA; Pavão, MS; Pecly, IM; Rangel, EP; Taboada, FS; Takiya, CM | 1 |
Braga, LM; Burin, M; Camassola, M; Dalberto, TP; Delgado-Cañedo, A; Giugliani, R; Matte, U; Nardi, NB | 1 |
Tollefsen, DM | 1 |
Baker, JR; Moring, AG; Norton, TT | 1 |
Fahey, M; Gohr, CM; Rosenthal, AK | 1 |
Hobbelen, PM; Meuleman, DG; Moelker, HC; van Dedem, G | 1 |
Blackwood, RA; Cantor, JO; Mandl, I; Moret, J; Turino, GM | 1 |
Deppmeier, L; Farrell, S; Grossmann, E; Johnson, E; Moore, CG; Morrison, J | 1 |
Cesmeli, S; Davies, AB; Gray, E; Lane, DA; Lormeau, JC | 1 |
Bellenger, CR; Ghosh, P; Little, CB | 1 |
Koide, N; Sasaki, S; Shinji, T; Tsuji, T | 1 |
Buczko, W; D'Adamo, MC; Donati, MB; Iacoviello, L; Pawlak, K; Polishchuck, R; Wollny, T | 1 |
Crawley, AC; Hopwood, JJ; Muller, VJ; Yogalingam, G | 1 |
Ghosh, P; Latham, J; Melrose, J; Moore, R; Taylor, TK; Vernon-Roberts, B | 1 |
Horie, K; Kyogashima, M; Miyauchi, S; Mizuno, S; Onaya, J; Sunose, A | 1 |
Arai, M; Kyogashima, M; Miyauchi, S; Onaya, J; Sakai, T; Shibata, Y; Suda, A; Takada, A; Takada, Y | 1 |
Mourão, PA; Pacheco, RG; Vicente, CP; Zancan, P | 1 |
Conard, J; Elalamy, I; Horellou, MH; Lecrubier, C; Samama, MM | 1 |
Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K | 1 |
Alves-Sá, R; Araújo, FS; Mourão, PA; Pavão, MS; Peixoto, LL; Vicente, CP; Zancan, P | 1 |
Cardin, AD; Driscoll, EM; Hennan, JK; Hong, TT; Lucchesi, BR; Shergill, AK | 1 |
Kischer, CW; Shetlar, CL; Shetlar, MR | 1 |
Alvarez, R; Fussi, F; Santoro, FM | 1 |
Ammitzbøll, T; Brok, KE; Jørgensen, B; Olsen, EB; Trier, K | 1 |
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
Barrowcliffe, TW; Merton, RE; Thomas, DP | 1 |
Oparil, S; Reynertson, RH; Rodén, L | 1 |
Boneu, B; Caranobe, C; Choay, J; Dol, F; Dupouy, D; Lormeau, JC; Petitou, M; Sié, P | 1 |
Constantopoulos, G; Hastings, N; Neufeld, EF; Shull, RM | 1 |
2 review(s) available for dermatan sulfate and Disease Models, Animal
Article | Year |
---|---|
Heparin cofactor II modulates the response to vascular injury.
Topics: Animals; Atherosclerosis; Coronary Restenosis; Dermatan Sulfate; Disease Models, Animal; Female; Heparin Cofactor II; Humans; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Pregnancy; Sensitivity and Specificity; Structure-Activity Relationship; Thrombin; Thrombosis; Tunica Intima | 2007 |
Heparin-induced thrombocytopenia: laboratory diagnosis and management.
Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Immunoassay; Platelet Activation; Recombinant Proteins; Thrombocytopenia | 2000 |
52 other study(ies) available for dermatan sulfate and Disease Models, Animal
Article | Year |
---|---|
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.
Topics: Animals; Biomarkers; Body Fluids; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Enzyme Replacement Therapy; Glycosaminoglycans; Heparitin Sulfate; Mice; Mice, Knockout; Mucopolysaccharidosis II | 2022 |
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
Topics: Administration, Oral; Animals; Cattle; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endothelial Cells; Female; Glycosaminoglycans; Glycosides; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mucopolysaccharidosis VI; Rats; Rats, Sprague-Dawley | 2020 |
High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
Topics: Animals; Biomarkers; Blood-Brain Barrier; Brain; Chromatography, Liquid; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronate Sulfatase; Mice; Mucopolysaccharidosis II; Tandem Mass Spectrometry | 2020 |
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.
Topics: Administration, Oral; Animals; Anticoagulants; Cattle; Collagen; Dermatan Sulfate; Disease Models, Animal; Enoxaparin; Male; Rabbits; Thrombelastography; Venous Thromboembolism; Venous Thrombosis | 2021 |
Extracellular Matrix Deposition and Remodeling after Corneal Alkali Burn in Mice.
Topics: Alkalies; Animals; Biomarkers; Burns, Chemical; Corneal Diseases; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Eye Burns; Fluorescent Antibody Technique; Gene Expression; Glycosaminoglycans; Heparitin Sulfate; Keratan Sulfate; Mice; Proteoglycans | 2021 |
Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.
Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Injections, Subcutaneous; Male; Mice; Mice, Inbred C3H; Otorhinolaryngologic Neoplasms; Radiation Injuries; Stomatitis; Tongue | 2018 |
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica.
Topics: Animals; Bone Diseases; Cell Differentiation; Decorin; Dermatan Sulfate; Disease Models, Animal; Dwarfism; Female; Fractures, Bone; Glycosylation; Golgi Matrix Proteins; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Transgenic; Osteoblasts; Proteoglycans; Signal Transduction; Skin Diseases, Genetic; Transforming Growth Factor beta; Vesicular Transport Proteins | 2018 |
Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.
Topics: Animals; Cell Proliferation; Dermatan Sulfate; Disease Models, Animal; Head and Neck Neoplasms; Hypoxia; Inflammation; Intercellular Junctions; Mice; Radiation-Protective Agents; Radiotherapy; Stomatitis | 2018 |
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
Topics: Animals; Biomarkers; Blood-Brain Barrier; Brain; Chromatography, Liquid; Dermatan Sulfate; Disease Models, Animal; Heparitin Sulfate; Humans; Iduronate Sulfatase; Mice; Mice, Knockout; Mucopolysaccharidosis II; Nervous System Diseases; Receptors, Transferrin; Tandem Mass Spectrometry | 2018 |
Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Anticoagulants; Bleomycin; Dermatan Sulfate; Disease Models, Animal; Female; Hydroxyproline; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis | 2019 |
Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.
Topics: Animals; Astrocytes; Axons; Brain Injuries; Chondroitin Sulfates; Cicatrix; Coculture Techniques; Dermatan Sulfate; Disease Models, Animal; Fibroblasts; Fluorescent Antibody Technique; Immunohistochemistry; Male; Mice; Mice, Inbred ICR; Nerve Regeneration; Rats; Rats, Sprague-Dawley | 2013 |
Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle.
Topics: Animals; Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Estradiol; Estrous Cycle; Female; Glycosaminoglycans; Heparitin Sulfate; Hyperprolactinemia; Metoclopramide; Mice; Progesterone; Time Factors; Uterus | 2013 |
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model.
Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Chondroitin Sulfate Proteoglycans; Dermatan Sulfate; Diet, Atherogenic; Disease Models, Animal; Extracellular Matrix; Gene Expression Regulation; Glycosaminoglycans; Goats; Humans; Hypercholesterolemia; Lipids; Male; Plaque, Atherosclerotic; Rabbits; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Dermatan sulfate epimerase 1 deficient mice as a model for human abdominal wall defects.
Topics: Abdominal Wall; Animals; Carbohydrate Epimerases; Dermatan Sulfate; Dermis; Disease Models, Animal; Embryo, Mammalian; Gene Expression; Hernia, Abdominal; Humans; Keratin-1; Keratin-15; Keratinocytes; Mice; Mice, Knockout; Neural Tube Defects; Spinal Dysraphism | 2014 |
Germline ablation of dermatan-4O-sulfotransferase1 reduces regeneration after mouse spinal cord injury.
Topics: Animals; Behavior, Animal; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Mice; Motor Activity; Nerve Regeneration; Recovery of Function; Spinal Cord Injuries; Sulfotransferases | 2016 |
Structural characterization and anti-inflammatory activity of two novel polysaccharides from the sea squirt, Ascidiella aspersa.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Dermatan Sulfate; Disease Models, Animal; Glycosaminoglycans; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Polysaccharides; Urochordata | 2016 |
Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II.
Topics: Animals; Antibodies, Anti-Idiotypic; Bone Marrow Transplantation; Dermatan Sulfate; Disease Models, Animal; Glycoproteins; Heparitin Sulfate; Humans; Lysosomes; Mice; Mice, Knockout; Mucopolysaccharidosis II; Proto-Oncogene Proteins c-kit | 2016 |
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Topics: Animals; Biomarkers; Blood Specimen Collection; Dermatan Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heparin Cofactor II; Heparitin Sulfate; Humans; Mice; Mice, Inbred C57BL; Mucopolysaccharidosis I; Mucopolysaccharidosis III; Thrombin | 2010 |
Danaparoid sodium attenuates the effects of heat stress.
Topics: Acute Disease; Animals; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Cytokines; Dermatan Sulfate; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Heat Exhaustion; Heat Stroke; Heparitin Sulfate; HMGB1 Protein; Inflammation; Intestine, Small; Liver; Lung; Male; Nitrates; Nitric Oxide; Nitrites; Peptide Hydrolases; Rats; Rats, Wistar; Survival Rate | 2011 |
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
Topics: Animals; Bleomycin; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibroblasts; Glucuronosyltransferase; Humans; Hyaluronic Acid; Idiopathic Pulmonary Fibrosis; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Distribution; Transforming Growth Factor beta1; Up-Regulation | 2011 |
Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction.
Topics: Animals; Anti-Inflammatory Agents; Chemokine CCL2; Dermatan Sulfate; Disease Models, Animal; Fibrosis; Injections, Subcutaneous; Kidney; Macrophage Activation; Macrophages; Male; Mice; Myofibroblasts; Nephritis; Transforming Growth Factor beta; Ureteral Obstruction | 2011 |
Mixture of hyaluronic acid, chondroitin 6 sulphate and dermatan sulphate used to completely regenerate bone in rat critical size defect model.
Topics: Animals; Biocompatible Materials; Bone Diseases; Bone Regeneration; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Hyaluronic Acid; Male; Neovascularization, Physiologic; Osteogenesis; Parietal Bone; Periosteum; Rats; Rats, Wistar; Time Factors; Wound Healing | 2012 |
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Bone Marrow Cells; CD4-Positive T-Lymphocytes; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Female; Glycosaminoglycans; Heparin; Humans; Hyaluronic Acid; Immunophenotyping; Mice; Mice, Inbred C57BL | 2002 |
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
Topics: Animals; Antithrombins; Carotid Artery Thrombosis; Dermatan Sulfate; Disease Models, Animal; Heparin Cofactor II; Humans; Mice; Mice, Knockout; Recombination, Genetic; Skin; Swine | 2004 |
Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
Topics: Animals; Anticoagulants; Arteries; Bleeding Time; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heparin Cofactor II; Male; Models, Chemical; Platelet Aggregation; Prothrombin Time; Recombinant Proteins; Thrombin; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator | 2006 |
Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration.
Topics: Animals; Biomarkers; Biopsy, Needle; Cell Movement; Chondroitin; Chondroitin Sulfate Proteoglycans; Collagen; Dermatan Sulfate; Disease Models, Animal; Down-Regulation; Fibronectins; Heparin, Low-Molecular-Weight; Immunohistochemistry; Kidney; Macrophages; Male; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Transforming Growth Factor beta; Up-Regulation; Ureteral Obstruction | 2006 |
Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.
Topics: Animals; Bone Marrow Transplantation; Dermatan Sulfate; Disease Models, Animal; DNA, Complementary; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glycosaminoglycans; Heparitin Sulfate; Humans; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucopolysaccharidosis I; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Transduction, Genetic; Transfection | 2005 |
Modulation of glycosaminoglycan levels in tree shrew sclera during lens-induced myopia development and recovery.
Topics: Animals; Chondroitin; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Capillary; Female; Hyaluronic Acid; Male; Myopia; Organ Size; Sclera; Sensory Deprivation; Tupaiidae | 2007 |
Calcific tendonitis : a model.
Topics: Animals; Calcinosis; Cartilage, Articular; Collagen Type I; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Glycerophosphates; Levamisole; Microscopy, Electron; Patellar Ligament; Sus scrofa; Tendinopathy | 2007 |
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
Topics: Animals; Blood Coagulation; Blood Platelets; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Male; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Thrombophlebitis | 1982 |
Glycosaminoglycan synthesis in endotoxin-induced lung injury.
Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endotoxins; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Lung; Pulmonary Emphysema; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Structure and composition of the rodent lamina cribrosa.
Topics: Animals; Chondroitin Sulfates; Collagen; Dermatan Sulfate; Disease Models, Animal; Glaucoma; Guinea Pigs; Immunoenzyme Techniques; Optic Disk; Rats; Rats, Inbred BN | 1995 |
Low affinity heparin is an antithrombotic agent.
Topics: Animals; Bleeding Time; Dermatan Sulfate; Disease Models, Animal; Hemorrhage; Heparin; Humans; Metabolic Clearance Rate; Rabbits; Thrombin; Thrombophlebitis | 1994 |
Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
Topics: Aggrecans; Animals; Biglycan; Cartilage, Articular; Chondroitin Sulfate Proteoglycans; Culture Media; Decorin; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Lectins, C-Type; Male; Menisci, Tibial; Osteoarthritis; Proteoglycans; Sheep | 1996 |
Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Galactosamine; Heparitin Sulfate; Immunohistochemistry; Liver; Liver Diseases; Male; Microscopy, Electron; Proliferating Cell Nuclear Antigen; Proteoglycans; Rats; Rats, Sprague-Dawley | 1996 |
Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
Topics: Animals; Anticoagulants; Dermatan Sulfate; Disease Models, Animal; Drug Therapy, Combination; Glycosaminoglycans; Heparin; Male; Rats; Thrombosis | 1996 |
Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
Topics: Animals; Arthrography; beta-N-Acetylhexosaminidases; Cats; Chondro-4-Sulfatase; Dermatan Sulfate; Disease Models, Animal; Female; Genotype; Humans; Joints; Leukocytes; Male; Mucopolysaccharidosis VI; Mutation; Pedigree; Phenotype | 1998 |
Elevated synthesis of biglycan and decorin in an ovine annular lesion model of experimental disc degeneration.
Topics: Animals; Autoradiography; Biglycan; Blotting, Western; Cell Division; Cells, Cultured; Chromatography, Gel; Decorin; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Intervertebral Disc; Proteoglycans; Sheep; Spinal Osteophytosis | 1997 |
Effects of dermatan sulfate, a heparin cofactor II mediated thrombin inhibitor, on the endotoxin-induced disseminated intravascular coagulation model in the rat: comparison with low-molecular weight heparin, nafamostat mesilate and argathroban.
Topics: Animals; Arginine; Benzamidines; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Guanidines; Heparin; Heparin Cofactor II; Male; Molecular Weight; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides | 1998 |
Antithrombotic activity of avian crown dermatan sulfate.
Topics: Animals; Anticoagulants; Cattle; Chickens; Chondroitin ABC Lyase; Chromatography, Gel; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation; Half-Life; Heparin Cofactor II; Male; Molecular Weight; Plasminogen; Rats; Species Specificity; Sulfatases; Thrombin; Tissue Plasminogen Activator; Venous Thrombosis | 1999 |
Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
Topics: Animals; Anticoagulants; Carbohydrate Sequence; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Echinodermata; Female; Fibrinolytic Agents; Fucose; Glycosaminoglycans; Heparin; Male; Molecular Sequence Data; Molecular Weight; Partial Thromboplastin Time; Rats; Sulfur Radioisotopes; Thrombosis | 2000 |
The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
Topics: Animals; Anticoagulants; Antithrombin III; Bleeding Time; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Factor Xa; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Kinetics; Male; Platelet Aggregation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin | 2001 |
Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
Topics: Animals; Anticoagulants; Blood Coagulation; Cattle; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hemorrhage; Heparin Cofactor II; Male; Protein Binding; Rats; Rats, Wistar; Species Specificity; Thrombin; Thrombosis; Urochordata | 2001 |
Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
Topics: Animals; Antithrombins; Bleeding Time; Carotid Arteries; Carotid Artery Thrombosis; Constriction, Pathologic; Dermatan Sulfate; Disease Models, Animal; Dogs; Injections, Intravenous; Jugular Veins; Platelet Aggregation; Venous Thrombosis | 2002 |
Healing of myocardial infarction in animal models.
Topics: Animals; Chondroitin Sulfates; Coronary Vessels; Dermatan Sulfate; Disease Models, Animal; Dogs; Glycosaminoglycans; Heart; Humans; Hyaluronic Acid; Middle Aged; Myocardial Infarction; Rats; Wound Healing | 1979 |
Pharmacological profile of a native dermatan sulfate.
Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Disease Models, Animal; Fibrinolysis; Male; Rats; Rats, Wistar; Thrombophlebitis | 1992 |
The effect of hyaluronic acid on cartilage in the immobilized rabbit knee.
Topics: Animals; Arthritis; Cartilage, Articular; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Evaluation Studies as Topic; Hyaluronic Acid; Immobilization; Injections, Intra-Articular; Keratan Sulfate; Knee Joint; Rabbits; Uronic Acids | 1991 |
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Glycosaminoglycans; Heparin; Oligosaccharides; Partial Thromboplastin Time; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis | 1989 |
Proteoglycans and hypertension: III: Aorta proteoglycans in Dahl salt-sensitive hypertensive rats.
Topics: Animals; Aorta; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Hyaluronic Acid; Hypertension; Male; Proteoglycans; Rats; Sodium Chloride | 1987 |
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.
Topics: Animals; Chondroitin; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Half-Life; Humans; Metabolic Clearance Rate; Partial Thromboplastin Time; Rabbits; Sulfuric Acids; Thrombosis | 1988 |
Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I).
Topics: Animals; Brain Chemistry; Brain Stem; Dermatan Sulfate; Disease Models, Animal; Dog Diseases; Dogs; Electrophoresis, Cellulose Acetate; Female; Gangliosides; Glycosaminoglycans; Glycoside Hydrolases; Heparitin Sulfate; Iduronidase; Molecular Weight; Mucopolysaccharidoses; Sciatic Nerve | 1985 |